NBV(新业务价值)

Search documents
中国人保(601319):人身险增长强劲、利润贡献上升
Xin Lang Cai Jing· 2025-03-28 10:35
2024 年公司人身险(寿险和健康险)NBV 可比口径下同比增长127%,其中代理人/银保渠道分别同比 +86%/223%。2024 年新单保费小幅下滑1%,NBV 增长由利润率提升驱动。2024 年预定利率再次下 调、"报行合一"挤压渠道费用,带动假设调整前的NBV 利润率(新单保费基准)改善至18%(前值 8%)。合同服务边际CSM/EV 分别同比大幅提升22%/21%,增长强劲。公司下调长期投资收益率至 4.0%(前值:分红万能4.75%/传统险4.5%),下调贴现率至8.5%(前值:9%),假设调整导致NBV 下 降约22%。考虑到公司NBV 利润率有望提升,我们预计公司2025 年NBV 增长17%。 财产险:综合成本率上升 公司公布2024 年业绩:2024 EPS RMB0.95 同比提升90%,主要因投资业绩高增,符合公司此前业绩预 告(同比增长75%-95%)。公司人身险NBV可比口径下同比提升127%,增长强劲。财险业务综合成本 率同比上升1pct至98.8%,主要受自然灾害因素影响。24 年人身险利润贡献增长至40%(23年6%),预 计25 年仍处于较高水平并对利润形成支撑,上调A 股 ...
中国太保(601601):NBV超预期增长57.7%,代理人规模止跌企稳
Shenwan Hongyuan Securities· 2025-03-27 15:20
Investment Rating - The report maintains a "Buy" rating for China Pacific Insurance (601601) [2][8] Core Views - The company's new business value (NBV) grew by 57.7% year-on-year, significantly exceeding expectations, while the agent scale has stabilized [6][8] - The company adjusted its long-term investment return assumptions down by 50 basis points to 4.0%, and the risk discount rate by 50 basis points to 8.5% [6] - The expected net profit for 2024 is projected at 44.96 billion yuan, representing a year-on-year increase of 64.9% [5][10] Financial Performance - For 2024, the company achieved a net profit of 44.96 billion yuan and an operating profit of 34.43 billion yuan, with year-on-year growth rates of 64.9% and 2.5% respectively [5][10] - The company's total revenue for 2024 is expected to be 404.09 billion yuan, reflecting a year-on-year growth of 24.7% [10][12] - The earnings per share (EPS) for 2024 is projected to be 4.67 yuan, with a year-on-year increase of 64.9% [10][12] Investment Performance - The company's investment income for 2024 is expected to reach 26.91 billion yuan, with a significant increase driven by the rebound in equity markets [8][12] - The total investment assets increased by 21.5% year-on-year to 27.3 trillion yuan, with equity assets contributing significantly [8] Market Data - As of March 27, 2025, the closing price of the stock is 32.20 yuan, with a market capitalization of 220.41 billion yuan [2][10] - The price-to-earnings (P/E) ratio for 2024 is projected at 6.89, indicating a favorable valuation [10][12]